Company: XCH
Filing Date: 2025-12-19
Form Type: F-3
Source: 0001193125-25-325891
Chunk: 2

Company: XCHG Ltd
Filing Date: 2025-12-19
Form: F-3
Chunk 2
---
) Class A Ordinary Shares, (iii) warrants, (iv) units, (v) subscription rights, and (vi) debt securities or any combination thereof (the “Securities”), in one or more offerings under this prospectus at prices and on terms described in one or more supplements to this prospectus. This prospectus describes some of the general terms that may apply to these Securities and the general manner in which they may be offered. This prospectus describes some of the general terms that may apply to these Securities and the general manner in which they may be offered. The specific terms of any Securities to be offered, and the specific manner in which they may be offered, will be described in one or more supplements to this prospectus. A prospectus supplement may also add, update or change information contained in this prospectus. We may also authorize one or more free writing prospectuses. You should read carefully this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as the documents incorporated or deemed to be incorporated by reference, before you invest in any of our Securities. The Securities covered by this prospectus may be offered and sold from time to time in the same offering or in separate offerings; to or through underwriters, dealers, and agents; or directly to purchasers. The names of any underwriters, dealers, or agents, if any, involved in the sale of our Securities, their compensation and any over-allotment options held by them will be described in the applicable prospectus supplement. For a more complete description of the plan of distribution of these Securities, see the section entitled “Plan of Distribution” beginning on page 27 of this prospectus. Our ADSs are listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “XCH.” On December 18, 2025, the closing trading price for the ADSs, as reported on the Nasdaq, was US$1.125 per ADS. Pursuant to General Instruction I.B.5 of Form F-3, in no event will we sell the Securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our voting and non-voting common equity held by non-affiliates in any 12-month period so long as the aggregate market value of our outstanding voting and non-voting common equity held by non-affiliates remains below US$75,000,000. During the 12 calendar months prior to and including the date of this prospectus